Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Contemporary Oncology
eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Research Gate
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2025
vol. 29
 
Share:
Send email
Share:
abstract:
Original paper

Lactobacillus brevis YNH inhibits proliferation of HeLa cells and promotes their apoptosis by modulating the PI3K/AKT pathway

Liang He
1
,
Dingji Tan
2
,
Rui Zhu
3
,
Jinglin Zhao
4
,
Hongli Yin
5
,
Ming Duan
1
,
Xin Li
1
,
Wen Fan
6
,
Zhiqin Yang
7
,
Xin Wang
5
,
Hongying Yang
5

  1. Department of Laboratory, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University Peking University Cancer Hospital Yunnan, Kunming, China
  2. Department of Laboratory, Chongqing Bishan Hospital of Traditional Chinese Medicine, Chongqing, China
  3. Department of Inspection Center, First People’s Hospital of Qujing City, Kunming, China
  4. Department of Laboratory, Kunming Children’s Hospital, Children’s Hospital Affiliated to Kunming Medical University, Kunming, China
  5. Department of Gynecology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University Peking University Cancer Hospital Yunnan, Kunming, China
  6. Department of Gynecology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
  7. Department of Gynecology, The First Affiliated Hospital of Kunming Medical University, Kunming, China
Contemp Oncol (Pozn) 2025; 29 (1): 55–68
DOI: https://doi.org/10.5114/wo.2025.148642
Online publish date: 2025/03/18
View full text Get citation
 
PlumX metrics:
Introduction
Existing treatments for cervical cancer have side effects on the human body. Some lactobacilli inhibit tumour progression in a strain-specific manner without toxic side effects.

Material and methods
We explored whether Lactobacillus brevis YNH isolated from the vagina has anti-cervical cancer effects by performing Cell Counting Kit 8 assays, flow cytometry, JC-1 staining, and western blotting. Transcriptome sequencing was performed to determine the possible mechanism. Xenograft tumour model mice that were orally administered Lactobacillus brevis YNH were used to validate the anticancer effects in vivo.

Results
Our study revealed that Lactobacillus brevis YNH downregulated the expression of cyclin E1 and CDK2, resulting in cell cycle arrest at S phase and inhibition of HeLa cell proliferation. In addition, HeLa cells treated with Lactobacillus brevis YNH significantly promoted the cleavage of caspase-3 and caspase-8, and increased the expression of Bax. Also, the mitochondrial membrane potential decreased, which induced apoptosis of HeLa cells. Most of the differentially expressed genes were enriched in the PI3K/AKT pathway, indicating that Lactobacillus brevis YNH might exert its anticancer effects through the PI3K/AKT pathway. Most importantly, we found that the tumour volume of mice was significantly smaller than control group after orally administered Lactobacillus brevis YNH, and biochemical results showed that Lactobacillus brevis YNH had no toxic side effects on the liver or kidney, suggesting that Lactobacillus brevis YNH has anti-cervical cancer effects in vivo.

Conclusions
This study revealed the anti-cervical cancer effects of Lactobacillus brevis YNH, providing a new candidate bioactive substance for the treatment of cervical cancer.

keywords:

Lactobacillus brevis YNH, cervical cancer, proliferation, apoptosis, PI3K/AKT
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.